Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

  • Switching ART to a more lipid-friendly regimen may be a reasonable approach in patients who are unable to achieve desired lipid goals through other means

    • This strategy is best undertaken in patients on an initial regimen, where lipid derangement is considered largely due to ART

    • Switching NRTIsSwitching to an NNRTI
      Switching to an Integrase or CCR5 Inhibitor
        Summary

        Action required

        Keywords: Cardiovascular Disease, Dyslipidemia, Switch Strategies, Treatment Complications

        ©2020 Clinical Care Options, LLC. All Rights Reserved.

        The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.